SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAHS Cancer Control Alberta
About this trial
The purpose of this study is to prospectively evaluate the feasibility of SBRT for the management of synchronous oligo metastatic liver metastases from colorectal cancers.
Eligibility criteria
Qualifiers
Age ≥ 18 years
ECOG (Eastern Cooperative Oncology Group) 0-2
Able to provide written informed consent
1-5 Liver lesions with max size of ≤5cm for a single lesion and restricted to one lobe of liver; deemed at Multi-Disciplinary Tumor Board (MDT) to be potentially amenable for SBRT with curative intent
Disqualifiers
Extra-hepatic metastases (except potentially resectable lung mets)
Not a suitable candidate for liver resection surgery
Not a suitable candidate for SBRT
Past history of cancer within 5 years (except basal cell carcinoma)
Trial design
Treatments tested in this trial
- stereotactic body radiation treatment (SBRT)
Treatment groups
24 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov